Celldex Therapeutics
CLDX
#5280
Rank
HK$8.74 B
Marketcap
HK$131.81
Share price
-6.67%
Change (1 day)
-59.55%
Change (1 year)

P/S ratio for Celldex Therapeutics (CLDX)

P/S ratio as of April 2025 (TTM): 161

According to Celldex Therapeutics's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 1.51. At the end of 2024 the company had a P/S ratio of 240.

P/S ratio history for Celldex Therapeutics from 2001 to 2024

PS ratio at the end of each year

Year P/S ratio Change
2024240-23.85%
2023315-64.62%
2022891129.46%
2021388314.91%
202093.5783.15%
201910.6184.57%
20183.72-87.72%
201730.3-42.63%
201652.8-81.29%
2015282-38.08%
2014456-13.25%
20135261263.33%
201238.6211.18%
201112.4338.95%
20102.82-71.05%
20099.75-41.89%
200816.823.99%
200713.5-33.39%
200620.3-55.02%
200545.1107.81%
200421.7-43.23%
200338.3274.72%
200210.2-85.9%
200172.4

P/S ratio for similar companies or competitors

Company P/S ratio P/S ratio differencediff. Country
18.8-88.35%๐Ÿ‡บ๐Ÿ‡ธ USA
0.3853-99.76%๐Ÿ‡บ๐Ÿ‡ธ USA
0.2579-99.84%๐Ÿ‡บ๐Ÿ‡ธ USA
4.95-96.92%๐Ÿ‡บ๐Ÿ‡ธ USA
2.20-98.63%๐Ÿ‡บ๐Ÿ‡ธ USA
1.93-98.80%๐Ÿ‡ฌ๐Ÿ‡ง UK
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA